9-136508861-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_017617.5(NOTCH1):c.3171+9G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000063 in 1,540,172 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000079 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000061 ( 0 hom. )
Consequence
NOTCH1
NM_017617.5 intron
NM_017617.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.606
Publications
0 publications found
Genes affected
NOTCH1 (HGNC:7881): (notch receptor 1) This gene encodes a member of the NOTCH family of proteins. Members of this Type I transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple different domain types. Notch signaling is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells through binding of Notch family receptors to their cognate ligands. The encoded preproprotein is proteolytically processed in the trans-Golgi network to generate two polypeptide chains that heterodimerize to form the mature cell-surface receptor. This receptor plays a role in the development of numerous cell and tissue types. Mutations in this gene are associated with aortic valve disease, Adams-Oliver syndrome, T-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, and head and neck squamous cell carcinoma. [provided by RefSeq, Jan 2016]
NOTCH1 Gene-Disease associations (from GenCC):
- Adams-Oliver syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet
- Adams-Oliver syndrome 5Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
- aortic valve disease 1Inheritance: AD Classification: STRONG Submitted by: G2P, PanelApp Australia
- connective tissue disorderInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- leukodystrophyInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- familial bicuspid aortic valveInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 9-136508861-C-T is Benign according to our data. Variant chr9-136508861-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 221043.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.0000612 (85/1387922) while in subpopulation MID AF = 0.000739 (3/4058). AF 95% confidence interval is 0.000295. There are 0 homozygotes in GnomAdExome4. There are 52 alleles in the male GnomAdExome4 subpopulation. Median coverage is 35. This position passed quality control check.
BS2
High AC in GnomAd4 at 12 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152250Hom.: 0 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
12
AN:
152250
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000122 AC: 18AN: 147492 AF XY: 0.000152 show subpopulations
GnomAD2 exomes
AF:
AC:
18
AN:
147492
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000612 AC: 85AN: 1387922Hom.: 0 Cov.: 35 AF XY: 0.0000761 AC XY: 52AN XY: 682976 show subpopulations
GnomAD4 exome
AF:
AC:
85
AN:
1387922
Hom.:
Cov.:
35
AF XY:
AC XY:
52
AN XY:
682976
show subpopulations
African (AFR)
AF:
AC:
1
AN:
31396
American (AMR)
AF:
AC:
0
AN:
35536
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
24944
East Asian (EAS)
AF:
AC:
15
AN:
35526
South Asian (SAS)
AF:
AC:
32
AN:
78882
European-Finnish (FIN)
AF:
AC:
0
AN:
47346
Middle Eastern (MID)
AF:
AC:
3
AN:
4058
European-Non Finnish (NFE)
AF:
AC:
29
AN:
1072862
Other (OTH)
AF:
AC:
5
AN:
57372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152250Hom.: 0 Cov.: 34 AF XY: 0.0000538 AC XY: 4AN XY: 74382 show subpopulations
GnomAD4 genome
AF:
AC:
12
AN:
152250
Hom.:
Cov.:
34
AF XY:
AC XY:
4
AN XY:
74382
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41474
American (AMR)
AF:
AC:
0
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5198
South Asian (SAS)
AF:
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
11
AN:
68032
Other (OTH)
AF:
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.529
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Jul 30, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Adams-Oliver syndrome 5 Benign:1
Dec 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.